Guided Therapeutics (GTHP) Return on Sales (2010 - 2025)
Guided Therapeutics recorded quarterly Return on Sales of 0.02% in Q4 2025, up 83.31% quarter-over-quarter from 0.12% in Q3 2025, and up 650.0% year-over-year from 0.0% in Q4 2024.
Guided Therapeutics' Return on Sales history runs 16 years deep, the most recent figure standing at 0.02% for Q4 2025.
- In Q4 2025, Return on Sales rose 650.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.04% (up 341.0% YoY), while the FY2025 annual figure was 0.04%, up 341.0% from the prior year.
- Return on Sales came in at 0.02% for Q4 2025 at Guided Therapeutics, up from 0.12% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.04% in Q3 2021 to a low of 24.42% in Q1 2025.
- A 5-year average of 2.5% and a median of 0.57% in 2024 frame the typical range for Return on Sales.
- On a YoY basis, Return on Sales climbed as much as 650 bps in 2025 and fell as far as 2375 bps in 2025.
- Guided Therapeutics' Return on Sales stood at 0.07% in 2021, then plunged by 4414 bps to 3.34% in 2022, then soared by 96 bps to 0.12% in 2023, then tumbled by 5305 bps to 6.52% in 2024, then surged by 100 bps to 0.02% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.02%, 0.12%, and 0.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -24.42% |
| Dec 31, 2024 | -6.52% |
| Sep 30, 2024 | -0.57% |
| Jun 30, 2024 | -0.57% |
| Mar 31, 2024 | -0.67% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.74% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -0.40% |
| Dec 31, 2022 | -3.34% |
| Sep 30, 2022 | -3.67% |
| Jun 30, 2022 | -1.85% |
| Mar 31, 2022 | -1.01% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | 0.04% |
| Jun 30, 2021 | -5.17% |
| Mar 31, 2021 | -0.35% |
| Dec 31, 2020 | 0.87% |
| Sep 30, 2020 | 0.20% |
| Jun 30, 2020 | -1.80% |
| Mar 31, 2020 | 0.57% |
| Dec 31, 2019 | 0.68% |
| Sep 30, 2019 | -1.26% |
| Jun 30, 2019 | -26.63% |
| Mar 31, 2019 | -0.12% |
| Dec 31, 2018 | -0.65% |
| Sep 30, 2018 | -3.73% |
| Jun 30, 2018 | 4.28% |
| Mar 31, 2018 | 2.71% |
| Dec 31, 2017 | -0.82% |
| Sep 30, 2017 | -0.72% |
| Jun 30, 2017 | -0.12% |
| Mar 31, 2017 | -0.05% |
| Dec 31, 2016 | 0.04% |
| Sep 30, 2016 | -0.02% |
| Dec 31, 2015 | -1.95% |
| Sep 30, 2015 | -2.74% |
| Jun 30, 2015 | -1.71% |
| Mar 31, 2015 | -0.83% |
| Dec 31, 2014 | 12.74% |
| Sep 30, 2014 | -1.35% |
| Jun 30, 2014 | -1.96% |
| Mar 31, 2014 | 0.82% |
| Dec 31, 2013 | 0.06% |
| Sep 30, 2013 | 0.17% |
| Jun 30, 2013 | 0.08% |
| Mar 31, 2013 | 0.11% |
| Dec 31, 2012 | 0.01% |
| Sep 30, 2012 | 0.01% |
| Jun 30, 2012 | -0.01% |
| Mar 31, 2012 | 0.01% |
| Dec 31, 2011 | 0.03% |
| Sep 30, 2011 | 0.03% |
| Jun 30, 2011 | 0.01% |
| Mar 31, 2011 | 0.01% |
| Jun 30, 2010 | -0.01% |